Skip to main content
OpenTrials
Completed

NCT Number: NCT00478478

Merci Registry - Real World Use of the Merci Retrieval System in Acute Ischemic Stroke

Post-Market Registry on Use of Merci Retrieval System. Primary data to be collected will include:

* Post-procedure revascularization success * 90-day mRS 0-2 * 90-day mortality

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Ischemic Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Embolism Embolism and Thrombosis Ischemia Nervous System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Stroke Thrombosis Vascular Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

St. Luke's Brain and Stroke Institute

Kansas City, Missouri, 64111, United States

About this study

The Merci Registry is a prospective multicenter registry with up to 3000 patients enrolled at a maximum of 100 sites.

The registry requires use (at least one pass in the intracranial vasculature) of any Merci Retriever device (X Series, L Series, V Series) in the setting of acute ischemic stroke due to large vessel intracranial occlusion.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient with ischemic stroke is treated with a Merci Retriever that is indicated for thrombus removal in ischemic stroke. "Treated" is defined as being when a Merci Retriever is deployed in the neurovasculature of a patient with an ischemic stroke
  • Patient/patient's surrogate provides informed consent and is willing to comply with the protocol requirements and complete required clinical evaluations, or in the absence of informed consent, an IRB/EC approved waiver of consent and executed data use agreement are in place

Exclusion criteria

-There are no exclusion criteria for this protocol

Treatment and study plan

Mechanical thrombectomy

Procedure

Thrombectomy performed with the Merci Retriever in the setting of acute ischemic stroke.

Other names: Merci Retrieval System

Primary outcomes

  1. Post-procedure revascularization success

    Time frame: post-procedure

Secondary outcomes

  1. NIHSS change from baseline to 24-hours

    Time frame: 24-hour

  2. 90-day mRS outcomes

    Time frame: 90-day

  3. 90-day mortality

    Time frame: 90-day

Sponsors and collaborators

Lead sponsor

Stryker Neurovascular

Industry

Registry information

Important dates

Study start
2007
Primary completion
2010
Study completion
2010
First posted
May 24, 2007
Registry last updated
Nov 10, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.